Adaptive Biotechnologies
Karen Chen is a research scientist at Adaptive Biotechnologies Corp. since September 2021, with prior roles as a senior scientist and scientist at PPD from June 2018 to August 2021. Karen's academic journey includes a graduate student position at the University of Wisconsin-Madison, where a thesis focused on combinational therapy for lung cancer was completed. Earlier experience includes research fellow positions at Academia Sinica and National Taiwan University Hospital, focusing on drug discovery and stem cell research, respectively. Educational qualifications include a Master of Science in Biotechnology and Laboratory Science in Medicine from National Yang Ming University.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.